jueves, 1 de diciembre de 2022

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

Study provides novel therapeutic targets for enhancing the antitumor immunity of γδ-T cells in diabetes

No hay comentarios:

Publicar un comentario